Antrogen Designated as RMAT for Diabetic Foot Ulcer Treatment in the US
[Asia Economy Reporter Minji Lee] Antrogen announced on the 20th that its diabetic foot ulcer treatment has been designated as a Regenerative Medicine Advanced Therapy (RMAT) by the US FDA.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Cellphone Dropped Under Reversing Car... Car Owner Asks, "Do I Have to Pay for Repairs?"
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
The company stated, "This is a treatment for severe diabetic foot ulcers for which there is no existing therapy," and added, "With the application of priority review, systematic communication with the FDA has shortened the review period for market approval and increased the likelihood of successful product authorization."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
